Take Heart Emerging Pharma! The History of Ariad Pharmaceuticals is a Lesson For Us All
By DeeDee DeMan – Bench is honored to have supported the rebuilding of Ariad at a difficult time for the company. In this new era the baton is passed to another devout oncology leader, Dr. Christophe Bianchi and Takeda, on behalf of leukemia patients. A salute to both physician leaders, Dr.’s Berger and Bianchi. Dr.’s Berger and Bianchi. It only took 25 years for Ariad to become, “An overnight success.” Emerging Pharma leaders, stay your course and keep your courage intact.
CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) today announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) (“ARIAD”) for $24.00 per share in cash. “We are very pleased to have completed the acquisition of ARIAD Pharmaceuticals.